
September 19th 2025
The Menopause Society Annual Meeting
If approved, the nonhormonal drug could offer an important new option for postmenopausal women seeking alternatives to hormone therapy.

September 18th 2025
The updated prescribing information includes phase 3b BATURA trial results showing a 46% reduction in severe exacerbations in mild asthma vs albuterol.

September 15th 2025
Most parents support childhood vaccines such as MMR and polio, but skepticism about seasonal and newer shots persists, along with distrust of federal agencies.

September 15th 2025
A single dose of neffy was effective in nearly 90% of patients treated for anaphylactic reactions during oral food challenge and allergen immunotherapy.
September 12th 2025
Teresa Lovins, MD, talked with Patient Care about suicidal ideation among patients and then focused on asking her colleagues to make their own mental health a priority.
September 9th 2025
Family physician Teresa Lovins, MD, explains how primary care clinicians can determine when to manage depression and when urgent referral is needed.
August 20th 2025
William Schaffner, MD, advises first and foremost to stay away from politics, to acknowledge and normalize patient fear and concern, and to answer quickly and with confidence.
.jpg?fit=crop&auto=format)
August 19th 2025
Sarah Sams, MD, emphasizes education, empathy, and proactive communication to support families and protect public health.
August 6th 2025
If primary care clinicians are to meet the cognitive screening demands that are growing with an aging population, they need the sharpest tools in the box, this expert says.

July 25th 2025
The Menopause Society Annual Meeting
Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.